The sixth presentation of the day at October's HCV Action Hepatitis C ODN Stakeholder Event 2022, an update on the elimination programme from Gilead Sciences.
Delivered by Dr William McCully, Patient Access to Care Director at Gilead Sciences, and Tracey Kemp, National Hepatitis C Strategy Lead, at CGL.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 21 to 30 of 321 resources
-
ODN Event 2022: Elimination programme updates – Gilead Sciences
England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: Elimination programme updates - MSD
The seventh and penultimate talk of the HCV Action Hepatitis C ODN Stakeholder Event 2022, an update from MSD on the elimination programme. Given by Kuldip Sembhi, HCV Elimination Programme Lead at MSD, and Ray Cottington, Community Liaison Officer at University Hospitals of Leicester NHS Trust.England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: Elimination programme updates - AbbVie
The eighth and final talk of the day at October's HCV Action Hepatitis C ODN Stakeholder Event 2022 - an elimination programme update from AbbVie. Delivered by Natalie Wood, Business Unit Manager at AbbVie, and Sue Reilly, North East & Cumbria Peer Coordinator at The Hepatitis C Trust.England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
HCV Action National Hepatitis C ODN Stakeholder Event summary report
The HCV Action National Hepatitis C ODN Stakeholder Event 2022 took place on Tuesday 11th October at the University of Warwick and was simultaneously broadcast live via livestream. This summary report contains a write-up of the key themes from the event's presentations and breakout sessions.England 28 Oct 2022 Training, Reports & Research PDF -
Injecting Equipment Provision in Scotland 2021/22
This report from Public Health Scotland provides an update on injecting equipment provision in Scotland, which the report notes play "a key role in helping to reduce hepatitis C prevalence in Scotland". Among the information reported is the number of outlets, attendances and the types of injecting equipment distributed to people who use drugs.Scotland 19 Oct 2022 Reports & Research PDF -
National Hepatitis C ODN Stakeholder Event 2022 presentation slides
The presentation slides from the HCV Action National Hepatitis C ODN Stakeholder Event 2022, held at the University of Warwick on Tuesday 11th October 2022.England 18 Oct 2022 Strategy & Planning PDF -
Holding a Community BBV Testing Event: A guide by Hepatitis Scotland
This resource from Hepatitis Scotland provides a guide to organising and hosting a community BBV testing event.Scotland 26 Aug 2022 Tools & Templates, Strategy & Planning PDF -
Unlinked anonymous monitoring (UAM) survey of HIV and viral hepatitis among people who inject drugs (PWID) 2022 report
The 2022 report on findings of the unlinked anonymous monitoring survey of HIV and viral hepatitis among people who inject drugs contains updates on hepatitis C prevalence, testing uptake and care & treatment.UK 12 Aug 2022 Reports & Research PDF -
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
The WHO Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for five key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines.UK, Rest of World 01 Aug 2022 Reports & Research, Strategy & Planning PDF -
Webinar summary: three years to go - where are we in the journey to elimination? May 2022
Held in May 2022 – only three years from the 2025 NHS England target to eliminate hepatitis C as a significant public health concern – this webinar of the HCV Action network aimed to share information about the latest data on hepatitis C, what we can observe about trends from what we already have and what types of further data collection we need to fill gaps in our current knowledge and guide efforts towards elimination.England Reports & Research, Strategy & Planning PDF